4.5 Article

Auranofin, Et3PAuCl, and Et3PAul Are Highly Cytotoxic on Colorectal Cancer Cells: A Chemical and Biological Study

期刊

ACS MEDICINAL CHEMISTRY LETTERS
卷 8, 期 10, 页码 997-1001

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acsmedchemlett.7b00162

关键词

Auranofin; thioredoxin reductase; anticancer drugs; colorectal cancer; protein interaction; DNA interaction; in vivo experiments

资金

  1. Beneficentia Stiftung
  2. ITT (Istituto Toscano Tumori)
  3. Ente Cassa Risparmio Firenze (ECR)
  4. AIRC [IG-16049]
  5. COST Action [CM1105]
  6. University of Pisa [PRA_2017_25]
  7. AIRC-FIRC (Fondazione Italiana per la Ricerca sul Cancro) [18044]

向作者/读者索取更多资源

The solution behavior of auranofin, Et3PAuCl and Et3PAuI, as well as their interactions with hen egg white lysozyme, single strand oligonucleotide, and ds-DNA were comparatively analyzed through NMR spectroscopy, ESI-MS, ethidium bromide displacement, DNA melting and viscometric tests. The cytotoxic effects toward representative colorectal cancer cell lines were found to be strong and similar in the three cases and a good correlation could be established between the cytotoxicity and the ability to inhibit thioredoxin reductase; remarkably, in vivo acute toxicity experiments for Et3PAuI confirmed that, similarly to auranofin, this drug is well tolerated in a murine model. Overall, a very similar profile emerges for Et3PAuI and Et3PAuCl, which retain the potent cytotoxic effects of auranofin while showing some peculiar features. These results demonstrate that the presence of the thiosugar moiety is not mandatory for the pharmacological action, suggesting that the tuning of some relevant chemical properties such as lipophilicity could be exploited to improve bioavailability, with no loss of the pharmacological effects.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Chemistry, Inorganic & Nuclear

A biophysical study of the interactions of palladium(ii), platinum(ii) and gold(iii) complexes of aminopyridyl-2,2′-bipyridine ligands with RNAs and other nucleic acid structures

Francesca Binacchi, Cassandra Elia, Damiano Cirri, Corjan van de Griend, Xue-Quan Zhou, Luigi Messori, Sylvestre Bonnet, Alessandro Pratesi, Tarita Biver

Summary: Metal compounds are attractive ligands for various nucleic acids. Five metal complexes with aminopyridyl-2,2'-bipyridine tetradentate ligands and quasi-planar geometry were studied for their binding to different nucleic acid molecules. The binding preferences and structural features of the metal complexes were analyzed using spectroscopy and melting methods.

DALTON TRANSACTIONS (2023)

Article Biochemistry & Molecular Biology

Synthesis, Characterization and Photoactivation Studies on the Novel Pt(IV)-Based [Pt(OCOCH3)3(phterpy)] Complex

Giovanni Canil, Juan Gurruchaga-Pereda, Simona Braccini, Lorella Marchetti, Tiziana Funaioli, Fabio Marchetti, Alessandro Pratesi, Luca Salassa, Chiara Gabbiani

Summary: Photoactivatable Pt(IV) prodrugs have great potential as metal-based drugs due to their chemical inertness in oxidized form and selective targeting compared to Pt(II) compounds. A new Pt(IV) complex, soluble in water and unreactive until reduction, was synthesized. The complex exhibited rapid and efficient photoreduction with visible light, facilitated by a catalytic system based on flavin and NADH. The reactivity of the prodrug against biological targets was only observed after photoreduction to its Pt(II) analogue.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Review Biochemistry & Molecular Biology

Highlights of New Strategies to Increase the Efficacy of Transition Metal Complexes for Cancer Treatments

Ester Giorgi, Francesca Binacchi, Carlo Marotta, Damiano Cirri, Chiara Gabbiani, Alessandro Pratesi

Summary: Despite progress, cancer still poses challenges due to side effects, resistance, and poor selectivity of current metal-based therapies. New strategies reviewed include using heterobimetallic complexes containing different metal centers and conjugating metal complexes to target cancer cells. Examples of targeting organelles and the entire cancer cell were highlighted.

MOLECULES (2023)

Article Biochemistry & Molecular Biology

Chemical Modification of Auranofin Yields a New Family of Anticancer Drug Candidates: The Gold(I) Phosphite Analogues

Damiano Cirri, Andrea Geri, Lara Massai, Michele Mannelli, Tania Gamberi, Francesca Magherini, Matteo Becatti, Chiara Gabbiani, Alessandro Pratesi, Luigi Messori

Summary: A panel of four novel gold(I) complexes, inspired by the clinically established gold drug auranofin, were prepared and characterized. The differences in their interactions with model proteins were analyzed, and their cytotoxic effects on ovarian cancer cells were quantitated. These novel gold complexes showed potential as effective anticancer agents.

MOLECULES (2023)

Article Chemistry, Inorganic & Nuclear

Two novel Pd thiosemicarbazone complexes as efficient and selective antitumoral drugs

Tania Hidalgo, David Fabra, Raul Allende, Ana I. Matesanz, Patricia Horcajada, Tarita Biver, Adoracion G. Quiroga

Summary: Cancer is a leading cause of death worldwide, with nearly 10 million deaths in 2020. Palladium complexes have great potential as anticancer agents, offering advantages over platinum drugs such as better speciation control and lower toxicity. This study developed two novel complexes and thoroughly investigated their speciation in solution, demonstrating their stability and behavior towards nucleic acid models and serum proteins. Furthermore, these complexes showed higher efficiency and specificity compared to the benchmark cisplatin drug due to their lower toxicity to healthy cells.

INORGANIC CHEMISTRY FRONTIERS (2023)

Article Chemistry, Inorganic & Nuclear

An overview of recent advancements in anticancer Pt(IV) prodrugs: New smart drug combinations, activation and delivery strategies

Carlo Marotta, Ester Giorgi, Francesca Binacchi, Damiano Cirri, Chiara Gabbiani, Alessandro Pratesi

Summary: The discovery of cisplatin's antineoplastic properties in 1965 renewed the interest in metal complexes for medicinal applications. Researchers have been studying safer and more effective alternatives to cisplatin, including platinum(IV)-based compounds. These compounds have attracted attention because they can be reduced in cells to activate the platinum center and offer advantages such as reducing side effects. This review summarizes the recent achievements in the field of Pt(IV) prodrugs.

INORGANICA CHIMICA ACTA (2023)

Article Chemistry, Multidisciplinary

Promising anticancer agents based on 8-hydroxyquinoline hydrazone copper(II) complexes

Nadia Ribeiro, Ipek Bulut, Baris Sergi, Vivien Posa, Gabriella Spengler, Giuseppe Sciortino, Vania Andre, Liliana P. Ferreira, Tarita Biver, Valeria Ugone, Eugenio Garribba, Joao Costa-Pessoa, Eva A. Enyedy, Ceyda Acilan, Isabel Correia

Summary: This study reports the synthesis and characterization of a group of benzoylhydrazones and their Cu(II) complexes. The complexes exhibited moderate-to-strong interaction with bovine serum albumin and showed higher antiproliferative activity compared to the corresponding free ligand and cisplatin. Compound 8 demonstrated the most promising properties with low IC50 values, high induction of oxidative stress and DNA damage, resulting in high rates of apoptosis.

FRONTIERS IN CHEMISTRY (2023)

Article Pharmacology & Pharmacy

The Nanostructured Self-Assembly and Thermoresponsiveness in Water of Amphiphilic Copolymers Carrying Oligoethylene Glycol and Polysiloxane Side Chains

Elisa Guazzelli, Giuseppe Pisano, Marco Turriani, Tarita Biver, Manfred Kriechbaum, Frank Uhlig, Giancarlo Galli, Elisa Martinelli

Summary: Amphiphilic copolymers with varying hydrophilic side chain lengths were synthesized and self-assembled into nanostructures in water. The thermoresponsive properties of these copolymers can be modulated by changing their chemical composition and hydrophobic component content.

PHARMACEUTICS (2023)

Article Chemistry, Inorganic & Nuclear

Adding Diversity to a Diruthenium Biscyclopentadienyl Scaffold via Alkyne Incorporation: Synthesis and Biological Studies

Giulio Bresciani, Serena Boni, Tiziana Funaioli, Stefano Zacchini, Guido Pampaloni, Natalia Busto, Tarita Biver, Fabio Marchetti

Summary: We synthesized and evaluated the anticancer potential of two series of diruthenium biscyclopentadienyl carbonyl complexes. Novel dimetallacyclopentenone compounds (2-4) were obtained from the thermal reaction of [Ru2Cp2(CO)(μ-CO)(μ-η^1:η^3-C(Ph)C(Ph)C(O)}], 1, with alkynes HCCR [R = C5H4FeCp (Fc), 3-C6H4(Asp), 2-naphthyl; Cp = η(5)-C5H5, Asp = OC(O)-2-C6H4C(O)Me]. The resulting complexes showed cytotoxic activity against cancer cells, different interactions with nucleic acids, and production of ROS.

INORGANIC CHEMISTRY (2023)

Article Chemistry, Multidisciplinary

Cyclic Ruthenium-Peptide Conjugates as Integrin-Targeting Phototherapeutic Prodrugs for the Treatment of Brain Tumors

Liyan Zhang, Peiyuan Wang, Xue-Quan Zhou, Ludovic Bretin, Xiaolong Zeng, Yurii Husiev, Ehider A. Polanco, Gangyin Zhao, Lukas S. Wijaya, Tarita Biver, Sylvia E. Le Devedec, Wen Sun, Sylvestre Bonnet

Summary: Investigation of tumor-targeting photoactivated chemotherapy using a chiral ruthenium-based anticancer warhead conjugated to an RGD-containing peptide showed strong phototoxicity and tumor-killing effects both in vitro and in vivo. The designed ruthenium-chelating peptide had triple action by preventing biomolecule coordination, self-assembling into nanoparticles, and specifically binding to tumor cells. These results demonstrate the potential of light-sensitive integrin-targeted ruthenium-based compounds for brain cancer treatment.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2023)

Article Chemistry, Inorganic & Nuclear

Cisplatin binding to angiogenin protein: new molecular pathways and targets for the drug's anticancer activity

Giarita Ferraro, Vanessa Sanfilippo, Lorenzo Chiaverini, Cristina Satriano, Tiziano Marzo, Antonello Merlino, Diego La Mendola

Summary: This study investigates the interaction between cisplatin and angiogenin and explores the impact of this interaction on prostate cancer cells. The results reveal new molecular pathways and targets for the activity of cisplatin.

DALTON TRANSACTIONS (2023)

Review Chemistry, Inorganic & Nuclear

Diruthenium(ii,iii) paddlewheel complexes: effects of bridging and axial ligands on anticancer properties

Iogann Tolbatov, Elisabetta Barresi, Sabrina Taliani, Diego La Mendola, Tiziano Marzo, Alessandro Marrone

Summary: This article provides an overview of the application of diruthenium(ii,iii) paddlewheel complexes for anticancer purposes. The use of this coordinative construct allows for combining the pharmacological properties of the dimetallic ruthenium center with specific carboxylate ligands to produce new entities with improved biological profiles. These systems also enable multiple drug deliveries to the target site, but chemico-physical aspects need to be considered for effective complex design.

INORGANIC CHEMISTRY FRONTIERS (2023)

Article Biochemistry & Molecular Biology

The choice of μ-vinyliminium ligand substituents is key to optimize the antiproliferative activity of related diiron complexes

Beatrice Campanella, Simona Braccini, Giulio Bresciani, Michele De Franco, Valentina Gandin, Federica Chiellini, Alessandro Pratesi, Guido Pampaloni, Lorenzo Biancalana, Fabio Marchetti

Summary: Diiron vinyliminium complexes are promising organometallics with potential anticancer activity. The synthesis and evaluation of [Fe2Cp2(CO)(mu-CO){mu-eta(1):eta(3)-C(R-3)C(R-4)CN(R-1)(R-2)}]CF3SO3 (2a-c, 4a-d) complexes were performed, including their solubility in D2O, Log P-ow, stability in D2O/Me2SO-d(6) mixture, and antiproliferative activity against ovarian cancer cell lines A2780 and A2780cisR, as well as the nontumoral cell line Balb/3T3 clone A31. The cytotoxicity data of 50 vinyliminium complexes were correlated with the structural properties, showing a positive correlation between octanol-water partition coefficient and relative antiproliferative activity on ovarian cancer cell lines. However, the effects of different substituents provided guidelines for the development of novel, more effective compounds. Three additional complexes (4p-r) were designed, synthesized, and biologically investigated, revealing their ability to inhibit thioredoxin reductase enzyme and induce cancer cell production of reactive oxygen species.

METALLOMICS (2023)

暂无数据